Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

High Incidence of BK-Virus-Related Hemorrhagic Cystitis after Busulfan/Fludarabine Myeloablative Conditioning in Allogeneic Stem Cell Transplantation Recipients.

Gorgun Akpek, MD, MHS, Ashraf Badros, MD, Aaron P. Rapoport, MD, Kathleen Ruehle, RN, Kristen Barton, RN, Barry Meisenberg, MD, Saul Yanovich, MD

Blood (2006) 108 (11): 5254.

https://doi.org/10.1182/blood.V108.11.5254.5254

Published: 2006

Journal Articles

Clinical Presentation, Prognostic Factors and Treatment Outcome of Multiple Myeloma (MM) in African American (AA) Patients.

Ashraf Z. Badros, MD, Olga Goloubeva, PhD, Saranya Chumsri, MD, Kathleen Ruehle, RN, Yi Ning, PhD, Joann Meekins, PhD, Liliana Guedez, PhD, Aaron P. Rapoport, MD, Barry Meisenberg, MD, Gorgun Akpek, MD, Saul Yanovich, MD, Edward Sausville, MD, PhD

Blood (2006) 108 (11): 5024.

https://doi.org/10.1182/blood.V108.11.5024.5024

Published: 2006

Journal Articles

Human Brain Endothelial Cells (HUBEC) Can Expand Both Human Bone Marrow and Cord Blood SCID-Repopulating Cells (SRC) through Cell Contact Rather Than Soluble Factors.

Naoko Takebe, MD, PhD, Xiangfei Cheng, MD, PhD, Ann M. Farese, MS, Emily Welty, MS, Barry Meisenberg, MD, Thomas MacVittie, PhD

Blood (2005) 106 (11): 36.

https://doi.org/10.1182/blood.V106.11.36.36

Published: 2005

Journal Articles

Attenuation of Surface CXCR4 Down-Regulation in Human Cord Blood HSC during Ex Vivo Expansion Using the HUBEC Co-Culture System.

Naoko Takebe, MD, PhD, Thomas MacVittie, PhD, Xiangfei Cheng, MD, PhD, Ann M. Farese, MS, Emily Welty, MS, Barry Meisenberg, MD

Blood (2005) 106 (11): 1068.

https://doi.org/10.1182/blood.V106.11.1068.1068

Published: 2005

Journal Articles

Effect of the Proteasome Inhibitor Bortezomib in Combination with “DT-PACE” on Stem Cell Collection and Engraftment in Newly Diagnosed Multiple Myeloma (MM) Patients (Pts).

Ashrof Z. Badros, MD, Javier Bolaños-Meade, MD, Aaron Rapoport, MD, Bashi Ratterree, RN, Sabrina Natt, RN, Kathy Ruehle, RN, Kathy McNamara, RN, Edmund Cox, Sandy Westphal, Robert Fenton, MD, PhD, Barry Meisenberg, MD.

Blood (2004) 104 (11): 5007.

https://doi.org/10.1182/blood.V104.11.5007.5007

Published: 2004

Journal Articles

Phase II Trial of Oblimersen Sodium (G3139), Dexamethasone (Dex) and Thalidomide (Thal) in Relapsed Multiple Myeloma Patients (Pts).

Ashrof Z. Badros, MD, Olga Goloubeva, PhD, Bashi Ratterree, RN, Sabrina Natt, RN, Aaron Rapoport, MD, Javier Bolaños-Meade, MD, Ben Zhang, PhD, Jerry Zeldis, MD, PhD, Stanley Frankel, MD, Barry Meisenberg, MD, James Zwiebel, MD, J. Flaws, PhD, D. Tomic, PhD, Robert Fenton, MD, PhD

Blood (2004) 104 (11): 2400.

https://doi.org/10.1182/blood.V104.11.2400.2400

Published: 2004

NARROW

High Incidence of BK-Virus-Related Hemorrhagic Cystitis after Busulfan/Fludarabine Myeloablative Conditioning in Allogeneic Stem Cell Transplantation Recipients.

Clinical Presentation, Prognostic Factors and Treatment Outcome of Multiple Myeloma (MM) in African American (AA) Patients.

Human Brain Endothelial Cells (HUBEC) Can Expand Both Human Bone Marrow and Cord Blood SCID-Repopulating Cells (SRC) through Cell Contact Rather Than Soluble Factors.

Attenuation of Surface CXCR4 Down-Regulation in Human Cord Blood HSC during Ex Vivo Expansion Using the HUBEC Co-Culture System.

Effect of the Proteasome Inhibitor Bortezomib in Combination with “DT-PACE” on Stem Cell Collection and Engraftment in Newly Diagnosed Multiple Myeloma (MM) Patients (Pts).

Phase II Trial of Oblimersen Sodium (G3139), Dexamethasone (Dex) and Thalidomide (Thal) in Relapsed Multiple Myeloma Patients (Pts).

Email alerts

ASH Publications

American Society of Hematology

High Incidence of BK-Virus-Related Hemorrhagic Cystitis after Busulfan/Fludarabine Myeloablative Conditioning in Allogeneic Stem Cell Transplantation Recipients.

Clinical Presentation, Prognostic Factors and Treatment Outcome of Multiple Myeloma (MM) in African American (AA) Patients.

Human Brain Endothelial Cells (HUBEC) Can Expand Both Human Bone Marrow and Cord Blood SCID-Repopulating Cells (SRC) through Cell Contact Rather Than Soluble Factors.

Attenuation of Surface CXCR4 Down-Regulation in Human Cord Blood HSC during Ex Vivo Expansion Using the HUBEC Co-Culture System.

Effect of the Proteasome Inhibitor Bortezomib in Combination with “DT-PACE” on Stem Cell Collection and Engraftment in Newly Diagnosed Multiple Myeloma (MM) Patients (Pts).

Phase II Trial of Oblimersen Sodium (G3139), Dexamethasone (Dex) and Thalidomide (Thal) in Relapsed Multiple Myeloma Patients (Pts).

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only